U.S. Rep. Diana DeGette (D-CO) and former Rep. Larry Buchson (R-IN) released a Dec. 24, containing recommendations for consideration in the 119th Congress. The 黑料网® (黑料网®) provided comments informing the document last summer.
The 21st Century Cures Act (2016) addressed topics related to software oversight, data sharing, biomedical research funding and payment policy. Congress began to examine Cures Act-related gaps and opportunities in 2019, an effort that was coined “Cures 2.0,” and ultimately helped establish the Advanced Research Projects Agency for Health (ARPA-H).
The latest white paper, suggests focus areas for future Cures-related legislative activities, including changes to Medicare payment policy and local coverage determination processes, U.S. Preventive Services Task Force processes, clinical trials access, health information exchange, software/medical device oversight, and more.
黑料网 members with questions about Cures 2.0 can contact Michael Peters, 黑料网 Senior Director, Government Relations, or Katie Grady, 黑料网 Government Affairs Director.